Post

P

Polpharma S.A. (Starogard Gdański, Polska). 2024 revenue ~PLN3.5Mld. Largest Polish pharma. Cardiology, gastroenterology, CNS. Apo-Cardio, Polocard. API manufacturing. 7.5K employees.

We use recombinant albumin fusion to extend the circulating half-life.

8:52:53 PM · Jul 9, 2026
Sign in to reply and join the conversation.